6926 - 6950 of 8399 Results
Title
Year
-
OPENTitle: Regulation of Memory Formation by the Transcription Factor XBP1Journal Name: Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 1382End Page: 1394Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2016.01.028Best OA location URL: http://www.cell.com/article/S2211124716000498/pdfCitation Count: 154
-
RESTRICTEDTitle: Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synucleinJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 42Issue #: 1Start Page: 51End Page: 76Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/nan.12299Citation Count: 66
-
RESTRICTEDTitle: Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromesJournal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 4Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12940Citation Count: 10
-
OPENTitle: Prefrontal White Matter Structure Mediates the Influence of GAD1 on Working MemoryJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 41Issue #: 9Start Page: 2224End Page: 2231Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/npp.2016.14Best OA location URL: https://www.nature.com/articles/npp201614.pdfCitation Count: 27
-
RESTRICTEDTitle: Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor–Nuclear Receptor Related 1 Protein Dimer ActivationJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 59Issue #: 3Start Page: 1232End Page: 1238Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01702Citation Count: 16
-
OPENTitle: Converging mediators from immune and trophic pathways to identify Parkinson disease dementiaJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000193Best OA location URL: https://nn.neurology.org/content/nnn/3/1/e193.full.pdfCitation Count: 15
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases2016OPENTitle: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.12813Best OA location URL: https://doi.org/10.7554/elife.12813Citation Count: 925
-
RESTRICTEDTitle: Kinematic A daptive D eep B rain S timulation for R esting T remor in P arkinson's D iseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 426End Page: 428Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26482Citation Count: 123
-
RESTRICTEDTitle: Vocal tics in Tourette's syndromeJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 15Issue #: 3Start Page: e1End Page: e1Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)00021-1Citation Count: 4
-
RESTRICTEDTitle: Oral Inosine Persistently Elevates Plasma antioxidant capacity in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 3Start Page: 417End Page: 421Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26483Citation Count: 40
-
OPENTitle: Randomized Controlled Trial of a Home-Based Action Observation Intervention to Improve Walking in Parkinson DiseaseJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 97Issue #: 5Start Page: 665End Page: 673Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.apmr.2015.12.029Best OA location URL: https://europepmc.org/articles/pmc4844795?pdf=renderCitation Count: 45
- Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings2016OPENTitle: Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy FindingsJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 2Start Page: 250End Page: 256Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26476Best OA location URL: https://europepmc.org/articles/pmc4747813?pdf=renderCitation Count: 76
-
RESTRICTEDTitle: A suggested minimum standard deep brain stimulation evaluation for essential tremorJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 362Issue #:Start Page: 165End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.01.041Citation Count: 7
-
OPENTitle: Clinical signs in functional (psychogenic) gait disorders: a brief surveyJournal Name: Journal of Clinical Movement DisordersPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40734-016-0031-1Best OA location URL: https://doi.org/10.1186/s40734-016-0031-1Citation Count: 22
-
OPENTitle: Mood Differences Among Parkinson’s Disease Patients With Mild Cognitive ImpairmentJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 28Issue #: 3Start Page: 211End Page: 216Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.15090221Best OA location URL: https://neuro.psychiatryonline.org/doi/pdf/10.1176/appi.neuropsych.15090221Citation Count: 30
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease2016OPENTitle: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0072-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0072-9Citation Count: 233
-
OPENTitle: Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer’s Disease With Aggression or Agitation: The CitAD Randomized Clinical TrialJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 173Issue #: 5Start Page: 465End Page: 472Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2015.15050648Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2015.15050648Citation Count: 86
-
OPENTitle: Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2016.01.020Best OA location URL: https://europepmc.org/articles/pmc4753102?pdf=renderCitation Count: 91
-
OPENTitle: Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variantsJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000044Best OA location URL: https://ng.neurology.org/content/nng/2/1/e44.full.pdfCitation Count: 33
-
OPENTitle: Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control CasesJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2015.00507Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2015.00507/pdfCitation Count: 34
- Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study2016OPENTitle: Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/npjparkd.2015.27Best OA location URL: https://www.nature.com/articles/npjparkd201527.pdfCitation Count: 70
- The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR22016OPENTitle: The IgLON Family Member Negr1 Promotes Neuronal Arborization Acting as Soluble Factor via FGFR2Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2015.00089Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2015.00089/pdfCitation Count: 55
-
OPENTitle: Impairment of PARK14-dependent Ca2+ signalling is a novel determinant of Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/ncomms10332Best OA location URL: https://www.nature.com/articles/ncomms10332.pdfCitation Count: 92
-
RESTRICTEDTitle: Neural substrates of excessive daytime sleepiness in early drug naïve Parkinson's disease: A resting state functional MRI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 24Issue #:Start Page: 63End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.01.012Citation Count: 44
-
RESTRICTEDTitle: Detection of proteolytic signatures for Parkinson's diseaseJournal Name: Future NeurologyPublisher: Informa UK LimitedVol: 11Issue #: 1Start Page: 15End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/fnl.16.3Citation Count: 0